Completing data — refresh the page later to see the latest
623174-20-9CC(C)[C@H](NC(=O)[C@H](C(C)C)N(C)C)C(=O)N(C)[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NC(C)(C)C)C(C)C.ClOOKIODJYZSVHDO-QMYFOHRPSA-NSee also: Tasidotin (has active moiety).
623174-20-9DTXSID70211383CHEMBL2107376Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Danger
H361 (100%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]
P203, P260, P264, P270, P280, P318, P319, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 4 reports by companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
UsesTreatment of patients with advanced, refractory neoplasms (microtubule stabilizing agent).